Funding
$86.9M
Models
1
Overview
French medical robotics company developing the Epione robotic platform for CT-guided percutaneous tumor ablation, enabling minimally invasive treatment of abdominal, lung, and bone cancers. Founded in 2017 by a team of former Medtech SA engineers led by Bertin Nahum, the company is headquartered in Montpellier with a US subsidiary in Miami. Now part of Precision IO Group after acquiring NeuWave Medical in February 2026, with over 1,400 patients treated across Europe and the United States.
Verified record
- Verified deployments
- None on file
- Active incidents
- 4 incidents on file
DEPLOY Intelligence
Market intelligence for physical AI
Analyst-grade signals, competitive tracking, and investment context across the global physical AI landscape. Launching 2026.
Key facts
FDA cleared
CE marked
Acquired NeuWave Medical
CEO
Group CEO
Co-founders
Total funding
FDA clearance
CE mark
Parent company
Patients treated
Data & sources
Web sources
1
1 source backing this record.View all →
Models (1)
View all models →Quantum Surgical on the deployment map
Where Quantum Surgical's robots are verified operating. Explore the deployment map by place and type.
Relationships
Current leadership (4)
- Bertin Nahum President & Co-founderreported, not verified
- Kurt Azarbarzin CEO, Precision IO Groupreported, not verified
- Lucien Blondel CTO & Co-founderreported, not verified
- Fernand Badano Managing Director & Co-founderreported, not verified
Founders (3)
- Bertin Nahumcofounder
- Lucien Blondelcofounder
- Fernand Badanocofounder
Safety record
1 recall and 3 incidents on record (1 critical, 1 moderate, 2 minor). Most recent: Mar 2026.
Most recent: Mar 2026
Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.
Full safety record: incidents, sourcing, and exposure data →
Incidents affecting Quantum Surgical (4)
- Quantum Surgical receives FDA 510(k) clearance for Epione robot for all abdominal cancers2026-03-26 · Regulatory action
- FDA clears Quantum Surgical Epione robot for abdominal tumor ablation2025-03-26 · Regulatory action
- FDA Class 2 recall of Epione needle guide component due to rust2024-08-05 · Recall
- Patient death during Epione-assisted liver cancer ablation procedure in France2023-11-10 · Fatality
Includes incidents linked directly to this company, to its models, or to deployments of its models or under its operation. Retracted incidents are excluded from this view but remain reachable at their canonical URLs.
Recent coverage
Quantum Surgical in third-party press
Peer companies
- Johnson & Johnson3 models
- Intuitive Surgical2 models
- LEM Surgical2 models
- MicroPort MedBot2 models
- Neocis2 models
- Stryker2 models
Financial state
- Reporting basis
- private_reported
- Lifecycle stage
- growth
- Counterparty risk class
- low
Each numeric field carries its own basis marker. Aggregators report a number; this surface preserves the source class so verification depth travels with the value.
Partnerships (1)
- Quantum Surgical x NeuWave Medical with NeuWave Medical, Precision IO Groupinvestment
Funding rounds (4)
- Other2024-07-11
$33M(reported)
Investors: European Investment Bank
- Series B2021-10-19
$48M(reported)
Investors: Ally Bridge Group, European Investment Bank, Bpifrance, Caisse d'Epargne Languedoc-Roussillon
- Series A2018-06-11
$6M(reported)
Investors: Ally Bridge Group, Muhan Investment Company
- Seed2016-12-16
$53,000(reported)
Regulatory filings (1)
Recent activity
Every change to this record is dated, sourced, and independently verified where marked.
- Record createdJul 6, 2026
Added to the verified registry
- Incident recordedMar 26, 2026
Quantum Surgical receives FDA 510(k) clearance for Epione robot for all abdominal cancers
- Deployment verifiedVerifiedDec 4, 2025
Epione at Leeds, UK
- Deployment verifiedVerifiedJun 10, 2025
Epione at London, UK
- Incident recordedMar 26, 2025
FDA clears Quantum Surgical Epione robot for abdominal tumor ablation
Sources (1)
Common questions
- What is Quantum Surgical?
- French medical robotics company developing the Epione robotic platform for CT-guided percutaneous tumor ablation, enabling minimally invasive treatment of abdominal, lung, and bone cancers. Founded in 2017 by a team of former Medtech SA engineers led by Bertin Nahum, the company is headquartered in Montpellier with a US subsidiary in Miami. Now part of Precision IO Group after acquiring NeuWave Medical in February 2026, with over 1,400 patients treated across Europe and the United States.
- What does Quantum Surgical make?
- Quantum Surgical has 1 robot model on the DEPLOY registry: Epione (Quantum Surgical builds physical robots).
- Is Quantum Surgical publicly traded?
- Quantum Surgical is not an independent public company; it has been acquired, per the DEPLOY registry.
- Who competes with Quantum Surgical?
- On the DEPLOY registry, peer companies to Quantum Surgical building in the same form factors include Johnson & Johnson, Intuitive Surgical, LEM Surgical, MicroPort MedBot.
- Who is the CEO of Quantum Surgical?
- Bertin Nahum is the ceo of Quantum Surgical, per the DEPLOY registry.
- How can I invest in Quantum Surgical?
- Quantum Surgical has no separately traded stock; it has been acquired.
- Where is Quantum Surgical headquartered?
- Quantum Surgical is headquartered in Montpellier, France.
- How much funding has Quantum Surgical raised?
- Quantum Surgical has raised approximately $87M in disclosed funding on record in the DEPLOY registry.
- Who owns Quantum Surgical?
- Quantum Surgical has been acquired and is no longer independently owned.
- Where does Quantum Surgical operate robots?
- Quantum Surgical is a robot manufacturer and does not directly operate deployments on the DEPLOY registry. Its products are deployed by customer operators; see the company page for the verified deployment record.
- Is Quantum Surgical a top robotics company?
- On DEPLOY's intelligence score, which blends verified deployments, funding, hiring, media, safety, and IP signals, Quantum Surgical ranks in roughly the top 15% of companies tracked by the registry.
- Are there any incidents involving Quantum Surgical?
- 4 active incidents involving Quantum Surgical are on the DEPLOY registry. Each is a sourced, append-only record; retracted incidents are suppressed from this view.
- Is Quantum Surgical safe?
- Quantum Surgical has 4 active incidents on record in the DEPLOY registry. 1 recall and 3 incidents on record (1 critical, 1 moderate, 2 minor). Most recent: Mar 2026. Retracted incidents are excluded from this count.
Methodology: Verified · 1 source (no primary) · last reviewed 2026-07-09
Verification posture
Verified
Low confidence
Review state
Stable
Last reviewed 2026-07-09
Sources by quality tier
- 1
- unclassified
- Unclassified source
The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.
Methodology surface for Quantum Surgical.Peer companies
- Johnson & Johnson3 models
- Intuitive Surgical2 models
- LEM Surgical2 models
- MicroPort MedBot2 models
- Neocis2 models
- Stryker2 models
In the press
Recent coverage mentioning Quantum Surgical from third-party publications. Automatically surfaced; not part of the verified registry record.
Quantum Surgical Acquires NeuWave Medical, Inc.
Quantum Surgical acquired NeuWave Medical, whose microwave ablation technology is used in 70% of top US cancer centers, forming Precision IO Group with Kurt Azarbarzin as CEO.
King's College Hospital Becomes First in United Kingdom to Adopt Epione
King's College Hospital NHS Foundation Trust in London became the first UK hospital to install the Epione robotic platform for percutaneous tumor ablation.
FDA clears Quantum Surgical Epione robot for all abdominal cancers
Quantum Surgical received FDA 510(k) clearance for its Epione robotic-assisted platform for all abdominal cancer tumor ablation treatments.
Rush University System for Health Becomes First in Midwest to Acquire Quantum Surgical Robotic Platform
Rush University System for Health in Chicago became the first Midwest hospital to acquire the Epione robotic platform for treating abdominal cancer tumors.
France: Medical robotics company Quantum Surgical gets EIB loan to advance tumour treatment
EIB provided EUR 30M loan to Quantum Surgical to accelerate worldwide commercialization of Epione for treating abdominal and lung cancer, bringing total EIB financing to EUR 45M.
Quantum Surgical Secures 40 Million Euros to Support the Commercial Launch of Epione
Quantum Surgical raised EUR 40M (USD 48M) led by Ally Bridge Group with EUR 20M, plus EIB, Bpifrance, and Caisse d'Epargne, bringing total funding to EUR 50M.
Machine-readable surfaces
- Markdown mirror: /companies/quantum-surgical.md
- RSS feed: /companies/quantum-surgical/feed.xml
- JSON-LD: embedded in this page’s head
- REST API: /v1/companies/cb6a0ecc-6b4d-486d-9356-ea9c928ba0ed
- Revision history: /companies/quantum-surgical/history
- Data documentation: /data
- Query this programmatically: Deploy MCP
Peer companies
- Johnson & Johnson3 models
- Intuitive Surgical2 models
- LEM Surgical2 models
- MicroPort MedBot2 models
- Neocis2 models
- Stryker2 models
Video
Liver cancer ranks amongst the three most deadly cancers. Ideally, in order to ensure a high survival rate, early mini-invasive treatment is required on tumor
Discover a groundbreaking achievement in cancer care at Miami Cardiac and Vascular Institute and Miami Cancer Institute, part of Baptist Health South Florida. A
Quantum Surgical developed Epione®, a robot dedicated to the curative treatment of early-stage tumors. Epione® assists physicians like Professor DeBaere with c
Want to see more? SUBSCRIBE to watch the latest podcasts: https://bit.ly/2UgRa2S Connect with Joe: LINKEDIN: https://www.linkedin.com/in/joemullings FACEBOOK:
"Plenary sessions - A time for big technological bets - Robotics and automation Bertin NAHUM, President and Founder, Quantum Surgical More info about DigiWorld
In this interview, Bertin Nahum, CEO of Quantum Surgical, explains how its now commercial system Epione will advance cancer treatment with high-powered surgical
This podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions
Bertin Nahum on Scaling Surgical Robotics for Cancer Care In this episode, Bertin Nahum, President and co-founder of Quantum Surgical, shares his journey from
Bertin Nahum, CEO @Quantum Surgical in conversation with Anne-Helene Illich, Co-head Private Wealth Management Paris, @GoldmanSachs.
In the first episode, Nick speaks with Dr Lucien Blondel all about his journey and passion for surgical robotic development! Dr Lucien Blondel is the CTO and C
Reality vs attention
Quantum Surgical draws attention at the 37th percentile but verifies reality at the 93rd percentile among surgical robots. Hype Gap -55.6, 19th widest among surgical robots.
6-month trend
Analysis
Safety profile within acceptable range for category. Strong deployment footprint with 6 operational sites across 6 countries. Thin IP estate relative to category peers.
Signal flags
Dimension breakdown
Verified signal
Attention (reach, not merit)
DEPLOY Intelligence scores are computed from verified registry data: confirmed deployments, disclosed funding rounds, regulatory filings, active job listings, video viewership, and press coverage. Confidence ratings reflect data availability. Scores update nightly.
DEPLOY Indices — verified vs claimed
Last computed: Jul 19, 2026